NDC codes

353873 NDC codes with hospital pricing data in the network.

• NDC 63323028561 — ROPIVACAINE (PF) 2 MG/ML (0.2 %) INJECTION SOLUTION (2 hospitals, 1–10 samples)
• NDC 00054-0742-87 — ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER (4 hospitals, 1–10 samples)
• NDC 00781-3238-63 — ENOXAPARIN 30 MG/0.3 ML SUBCUTANEOUS SYRINGE (3 hospitals, 1–10 samples)
• NDC 63323-0106-01 — MAGNESIUM SULFATE 4 GRAM/100 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (3 hospitals, 1–10 samples)
• NDC 63323-0106-02 — MAGNESIUM SULFATE 2 GRAM/50 ML (4 %) IN WATER INTRAVENOUS PIGGYBACK (4 hospitals, 1–10 samples)
• NDC 63323-0642-20 — MAGNESIUM SULFATE 500 MG/ML (50 %) INJECTION SOLUTION (4 hospitals, 1–10 samples)
• NDC 67457-0218-10 — CLONIDINE (PF) 1,000 MCG/10 ML (100 MCG/ML) EPIDURAL SOLUTION (3 hospitals, 1–10 samples)
• NDC 17156-0526-05 — TECHNETIUM TC 99M SULFUR COLLOID (7 hospitals, 1–10 samples)
• NDC 17478-0042-10 — NALOXONE 0.4 MG/ML INJECTION SOLUTION (7 hospitals, 1–10 samples)
• NDC 38779-1938-05 — PHENOL (BULK) 89 % LIQUID (7 hospitals, 1–10 samples)
• NDC 60687-0272-11 — CEFUROXIME AXETIL 250 MG TABLET (3 hospitals, 1–10 samples)
• NDC 63323-0064-01 — MAGNESIUM SULFATE 500 MG/ML (50 %) INJECTION SOLUTION (3 hospitals, 1–10 samples)
• NDC 63323-0165-16 — DEXAMETHASONE SODIUM PHOSPHATE 4 MG/ML INJECTION SOLUTION (7 hospitals, 1–10 samples)
• NDC 63323-0269-10 — PROPOFOL INJECTION 10 MG/ML (NON-CONT) (3 hospitals, 1–10 samples)
• NDC 63323-0559-21 — ENOXAPARIN 30 MG/0.3 ML SUBCUTANEOUS SYRINGE (4 hospitals, 1–10 samples)
• NDC 63323-0559-93 — ENOXAPARIN 30 MG/0.3 ML SUBCUTANEOUS SYRINGE (4 hospitals, 1–10 samples)
• NDC 67457-0340-01 — VANCOMYCIN IV SYRINGE IN D5W 100 MG/ML INTERMITTENT PD DOSE (3 hospitals, 1–10 samples)
• NDC 67457-0380-12 — PARICALCITOL 5 MCG/ML INTRAVENOUS SOLUTION (7 hospitals, 1–10 samples)
• NDC 67457-0484-30 — RITUXIMAB 10 MG/ML CONCENTRATEINTRAVENOUS (2 hospitals, 1–10 samples)
• NDC 68180-0963-01 — ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER (4 hospitals, 1–10 samples)
• NDC 70461-0322-04 — GENTAMICIN 100 MG/100 ML IN SODIUM CHLORIDE(ISO) INTRAVENOUS PIGGYBACK (2 hospitals, 1–10 samples)
• NDC 70710-1517-02 — MEROPENEM 1 GRAM INTRAVENOUS SOLUTION (2 hospitals, 1–10 samples)
• NDC 76329-9061-00 — EPINEPHRINE MDV SOLN 1 MG/ML1 MG (3 hospitals, 1–10 samples)
• NDC 77888-8001-48 — AZITHROMYCIN 1 ML SYRINGE (6 hospitals, 1–10 samples)
• NDC 85920-0001-55 — HEPARIN PORCINE (PF) 10 UNIT/ML INTRAVENOUS SYRINGE (2 hospitals, 1–10 samples)
• NDC 00009-0728-09 — CLINDAMYCIN PHOSPHATE 9 GM/60ML INJ SOLN (2 hospitals, 1–10 samples)
• NDC 00054-0188-13 — BUPRENORPHINE 2 MG-NALOXONE 0.5 MG SUBLINGUAL TABLET (3 hospitals, 1–10 samples)
• NDC 00078-0149-23 — CALCITONIN (SALMON) 200 UNIT/ML INJECTION SOLUTION (10 hospitals, 1–10 samples)
• NDC 00234-0575-08 — CHLORHEXIDINE GLUCONATE 4 % TOPICAL LIQUID (1 hospital, 1–10 samples)
• NDC 00270-0556-15 — SINCALIDE 5 MCG SOLUTION FOR INJECTION (2 hospitals, 1–10 samples)
• NDC 00310-0321-30 — MEROPENEM 1 GRAM INTRAVENOUS SOLUTION (10 hospitals, 1–10 samples)
• NDC 00378-4201-78 — MYCOPHENOLATE SODIUM 180 MG TABLETDELAYED RELEASE (10 hospitals, 1–10 samples)
• NDC 00496-0882-06 — LIDOCAINE 4 % TOPICAL CREAM (4 hospitals, 1–10 samples)
• NDC 00597-0152-30 — EMPAGLIFLOZIN 10 MG TABLET (3 hospitals, 1–10 samples)
• NDC 00641-6006-01 — ATROPINE 0.4 MG/ML INJECTION SOLUTION (8 hospitals, 1–10 samples)
• NDC 00703-3678-81 — METHOTREXATE SODIUM (PF) 25 MG/ML INJECTION SOLUTION (10 hospitals, 1–10 samples)
• NDC 00781-3267-90 — MEROPENEM 1 GRAM INTRAVENOUS SOLUTION (10 hospitals, 1–10 samples)
• NDC 00781-7296-85 — ALBUTEROL SULFATE HFA 90 MCG/ACTUATION AEROSOL INHALER (4 hospitals, 1–10 samples)
• NDC 09999-9005-85 — METHYLENE BLUE 1 % (10 MG/ML) ORAL SOLUTION (10 hospitals, 1–10 samples)
• NDC 09999-9021-17 — AZACITIDINE 100 MG SOLUTION FOR INJECTION (10 hospitals, 1–10 samples)
• NDC 09999-9022-76 — OCTREOTIDE ACETATE 200 MCG/ML INJECTION SOLUTION (10 hospitals, 1–10 samples)
• NDC 16729-0549-10 — BUPRENORPHINE 2 MG-NALOXONE 0.5 MG SUBLINGUAL TABLET (1 hospital, 1–10 samples)
• NDC 17478-0501-01 — METHYLERGONOVINE MALEATE SOLN 0.2 MG/ML (1 ML)0 MG (3 hospitals, 1–10 samples)
• NDC 18657-0102-04 — HYALURONIDASE HUMAN RECOMBINANT 150 UNIT/ML INJECTION SOLUTION (10 hospitals, 1–10 samples)
• NDC 42023-0187-01 — DEXMEDETOMIDINE 400 MCG/100 ML (4 MCG/ML) IN 0.9 % SODIUM CHLORIDE IV (3 hospitals, 1–10 samples)
• NDC 50419-0320-05 — GADOXETATE 0.25 MMOL/ML (181.43 MG/ML) INTRAVENOUS SOLUTION (2 hospitals, 1–10 samples)
• NDC 51672-1312-01 — MUPIROCIN 2 % TOPICAL OINTMENT (1 hospital, 1–10 samples)
• NDC 54766-0149-23 — CALCITONIN (SALMON) 200 UNIT/ML INJECTION SOLUTION (10 hospitals, 1–10 samples)
• NDC 55566-8301-01 — DEGARELIX 80 MG SUBCUTANEOUS SOLUTION (10 hospitals, 1–10 samples)
• NDC 55566-8301-02 — DEGARELIX 80 MG SUBCUTANEOUS SOLUTION (10 hospitals, 1–10 samples)